#
Budesonide Capsule Delayed Release
  • Professionals
  • FDA PI

Budesonide Capsule Delayed Release

Dosage form: capsule, delayed release
Drug classes:Glucocorticoids, Inhaled corticosteroids

Medically reviewed by Drugs.com. Last updated on Dec 1, 2021.

Indications and Usage for Budesonide Capsule Delayed Release

Treatment of Mild to Moderate Active Crohn’s Disease

Budesonide delayed-release capsules are indicated for the treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon in patients 8 years of age and older.

Maintenance of Clinical Remission of Mild to Moderate Crohn’s Disease

Budesonide delayed-release capsules are indicated for the maintenance of clinical remission of mild to moderate Crohn’s disease involving the ileum and/or the ascending colon for up to 3 months in adults.

CONTACT INFORMATION

LINKS

MEDICAL DEPARTMENTS

Cardiology
Pediatrics
Diabetes Care
Pre-natal Care
Ultrasound Echocardiogram